While some developers are implementing lessons learned – and launching – their 2nd C>s to market, the majority are hoping the launch strategy for their 1st holds strong, as they navigate through a meteor shower of risky unknowns, firsts, new partnerships, and complexities the average pharma team has never experienced before.
To succeed commercially, pharma and biotech need to formulate a launch strategy that engages the right commercial resource early on, rewrites traditional payment models in partnership with payers, and provides an integrated delivery network that scales up seamlessly, end-to-end.
At Reuters Events' Cell & Gene Therapy USA 2021, you will receive key lessons learned from those who have already achieved lift off. C-suite, commercial strategy, manufacturing and supply, pricing and access experts will provide you with the tools to launch successfully and sustain and scale your cell and gene therapy delivery in to hyperdrive.
Suneet Varma Global President Pfizer Rare Diseases
Stefan Hendriks Global Head, Cell & Gene Novartis
Christine Coughlin Chief Medical Officer Rubius Therapeutics
Kristen Hege SVP Early Clinical Development, Hematology/Oncology & Cell Therapy BMS
Rita Johnson-Greene VP of Sales and Qualified Treatment Centers (QTCs) bluebird bio
Peter Marks Director, Center for Biologics Evaluation and Research (CBER) FDA
In-depth case studies
Practical, tangible advice and actions from your peers across the entire cell and gene value chain, that you can put into practise in your own company as you develop your commercialization strategy
A team learning experience
Now more than ever, we need to work together to effectively commercialize these incredible treatments for our customers and patients. Participate as a team of internal and external stakeholders to catch every drop of insight, make the most of networking and interactive sessions and unite to transform culture
Interactive at its core
We know you want more than just a series of online presentations – this is why live panels, real-time Q&A, virtual face-to-face workshops (pharma and biotech only) and online networking are all key experiences of Cell & Gene Therapy 2021 Virtual.
World-class online networking
Connect with like-minded attendees via a tried and tested, best-in-class platform, as well as interactive virtual workshops (pharma and biotech only) and social events to facilitate those chance encounters.
Benchmark against the leaders in cell & gene commercialization
We spend months uncovering the best examples of pharma and biotech going beyond business as usual in their attempts to commercialize effectively, with patient experience, speed of service and price at its core, so you can see how you compare against the leaders.
Align multiple stakeholders around the common cause
We get all the industry’s key stakeholders in the virtual room. Meet CROs, CDMOs, technology and solution providers, pharma and biotech with the collective aim of solving problems, speeding access and identifying patients in a constructive, collaborative manner
We know that a virtual event doesn’t always deliver on the “chance encounters” that can be so valuable from a physical conference, but with the networking and messaging suite at Cell & Gene Therapy USA, you’ll be guaranteed a service that allows you to connect with and meet attendees who are relevant to your business, interests and challenges.
Searchable attendee list
Private group chats
You won’t find an online cell and gene commercialization networking experience elsewhere. Reuters Events Pharma Cell & Gene Therapy USA 2021 is the only place to connect with commercialization leaders, patient experience experts, pricing and policy advisors, engagement and education front-runners. Here’s how:
* Company NPS scores acquired from https://customer.guru/net-promoter-score/top-brands
A special experience by any measure!
This is not our first rodeo. April this year we turned two of the industry’s largest events, Reuters Events Pharma (formerly eyeforpharma) Philadelphia and Barcelona, into virtual events in the space of a month. With over 30,000 total attendees, here’s what people thought…
Reuters Events has once again proven why they are the leaders in this space
Extremely interesting and provided great insights into the best practices and ways of moving forward in the future.
An extraordinary, pioneering job!
The content was superb and well done.
Excellent sessions providing great insights into the future of pharma.
Congratulations on the eyeforpharma virtual work! Very interesting talks and extremely well organised.
I’m grateful to Reuters Events for making it possible to connect.
This is a great forum and it's working so nicely. Deep and thoughtful exploration.
Congratulations and a huge thank you for this virtual event!
Excellent facilitation and fascinating discussions
Congratulations on the virtual eyeforpharma event! It was a great experience! Thank you for all the insights.
I couldn’t help but feel that I was witnessing the roots of the future being sown today.
Another successful event in Pharma at such challenging times
Holy Sh*t – so impressed!
Wonderful platform. Very valuable.
It was a sheer privilege and an honour to participate.
Thank you for arranging such an event; it is really inspiring and also motivating during this difficult period.
Thank you so much for providing this program virtually… I have learned so much.
It was a memorable experience for the industry.
Thanks for hosting this and having it free so patient advocates could really attend!
This was conference was very well done! Thank You.
Its an amazing way for networking.
This virtual conference turned out amazingly done! Good job!
The conference hits on everything I am passionate about.
Many thanks for educating all of us in this difficult time!
Get in touch with the Reuters Events team